Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate | Patent Number 09708342

US 09708342 B2
Application Number14744915
Publication NumberUS 20160016973 A1
Pendency2 years, 1 month
Filled DateJun 19, 2015
Priority DateJun 20, 2014
Publication DateJan 21, 2016
Expiration DateJun 19, 2034
Inventor/ApplicantsIrene Chen
Vahid Zia
Ernest A. Carra
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Assignments
Gilead Sciences
Current
Gilead Sciences
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.